Antioxidant supplements for prevention of gastrointestinal cancers: A systematic review and meta-analysis

Lancet

Volumn 364, Issue 9441, 2004, Pages 1219-1228

  Bjelakovic, Goran ^a,b,d   Nikolova, Dimitrinka ^a   Simonetti, Rosa G ^a,c   Gluud, Christian ^a  

^a C ^*  (Denmark)

^b UNIVERSITY OF NI   (Serbia)

^c VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^d UNIVERSITY OF NI   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; PLACEBO; RETINOL; SELENIUM;

ANTIOXIDANT ACTIVITY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CLINICAL TRIAL; COLORECTAL CANCER; DATA ANALYSIS; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM CANCER; DRUG EFFICACY; ESOPHAGUS CANCER; HUMAN; INTERMETHOD COMPARISON; LIVER CANCER; META ANALYSIS; METHODOLOGY; OXIDATIVE STRESS; PANCREAS CANCER; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; STOMACH CANCER;

EID: 4744372695     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17138-9     Document Type: Article

References (71)

1. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci USA. 92:1995;5258-5265
2. Sies H. Sies H. Oxidative stress. 1985;1-7 Academic Press, Orlando
3. Halliwell B, Zhao K, Whiteman M. The gastrointestinal tract: a major site of antioxidant action? Free Radic Res. 33:2000;819-830
4. Poppel G, Berg H. Vitamins and cancer. Cancer Lett. 114:1997;195-202
5. Diplock AT. Antioxidants and disease prevention. Mol Aspects Med. 15:1994;293-376
6. Sporn MB, Suh N. Chemoprevention of cancer. Carcinogenesis. 21:2000;525-530
7. Salganik RI. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr. 20 (suppl):2001;464S-472S
8. Thomson A, Hemphill D, Jeejeebhoy KN. Oxidative stress and antioxidants in intestinal disease. Dig Dis. 16:1998;152-158
9. Tamimi RM, Lagiou P, Adami HO, Trichopoulos D. Prospect for chemoprevention of cancer. J Intern Med. 251:2002;286-300
10. Pritchard DM, Watson AJ. Apoptosis and gastrointestinal pharmacology. Pharmacol Ther. 72:1996;149-169
11. Sihvo EIT, Salminen JT, Rantanen TK, et al. Oxidative stress has a role in malignant transformation in Barrett's oesophagus. Int J Cancer. 102:2002;551-555
12. Boyle P, Zaridze DG, Smans M. Descriptive epidemiology of colorectal cancer. Int J Cancer. 36:1985;9-18
13. Weisburger JH. Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids. Am J Clin Nutr. 53:1991;S226-S237
14. Poppel G. Epidemiological evidence for beta-carotene in prevention of cancer and cardiovascular disease. Eur J Clin Nutr. 50:(suppl 3):1996;S57-S61
15. Anonymous. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-1035.
16. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 334:1996;1150-1155
17. Lee BM, Park KK. Beneficial and adverse effects of chemopreventive agents. Mutat Res. 523-24:2003;265-278
18. Paolini M, Abdel-Rahman SZ, Sapone A, et al. Beta-carotene: a cancer chemopreventive agent or a co-carcinogen? Mutat Res. 543:2003;195-200
19. Alderson P, Green S, Higgins JPT, eds. Cochrane reviewers' handbook 4.2.5 (December, 2003). In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley and Sons.
20. Bjelakovic G, Nikolova D, Simonetti R. Antioxidants for preventing gastrointestinal cancers (protocol for a Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Oxford: Update Software.
21. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 352:1998;609-613
22. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 273:1995;408-412
23. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med. 135:2001;982-989
24. Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ. 323:2001;42-46
25. DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Stat Med. 6:1987;341-350
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 7:1986;177-188
27. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 21:2002;1539-1558
28. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 326:2003;219
29. Munoz N, Wahrendorf J, Bang LJ, et al. No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesions of oesophagus: randomised double-blind intervention study in high-risk population of China. Lancet. 326:1985;111-114
30. Yu SY, Zhu YJ, Li WG, et al. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res. 29:1991;289-294
31. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 85:1993;1483-1492
32. Li JY, Taylor PR, Li B, et al. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst. 85:1993;1492-1498
33. Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA. 276:1996;1957-1963
34. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 334:1996;1145-1149
35. Yu SY, Zhu YJ, Li WG. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res. 56:1997;117-124
36. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. Randomised beta-carotene supplementation and incidence of cancer and cardiovascular disease in women: the Women's Health Study. J Natl Cancer Inst. 91:1999;2102-2106
37. Li W, Zhu Y, Yan X, et al. The prevention of primary liver cancer by selenium in high-risk populations. Zhonghua Yu Fang Yi Xue Za Zhi. 34:2000;336-338
38. Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst. 92:2000;1881-1888
39. Zhu S, Mason J, Shi Y, et al. The interventional effect of folic acid on the development of gastric and other gastrointestinal cancers - clinical trial and follow-up for seven years. Chin J Gastroenterol. 7:2002;73-78
40. Anonymous. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 23-33.
41. Panel on micronutrients, subcommittees on upper reference levels of nutrients and of interpretation and use of dietary reference intakes, and the standing committee on the scientific evaluation of dietary reference intakes. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press, 2000: 1-800.
42. Panel on dietary antioxidants and related compounds, subcommittees on upper reference levels of nutrients and interpretation and uses of DRIs, standing committee on the scientific evaluation of dietary reference intakes. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press, 2000: 1-529.
43. Caraballoso M, Sacristan M, Serra C, Bonfill X. Drugs for preventing lung cancer in healthy people (Cochrane Review). In: The Cochrane Library, Issue 2, 2004. Oxford: Update Software.
44. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 361:2003;2017-2023
45. van den Broek N, Kulier R, Gülmezoglu AM, Villar J. Vitamin A supplementation during pregnancy (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Oxford: Update Software.
46. Darlow BA, Graham PJ. Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Oxford: Update Software.
47. Glasziou PP, Mackerras DE. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ. 306:1993;366-370
48. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature. 392:1998;559
49. Hercberg S, Preziosi P, Galan P, et al. "The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. Food Chem Toxicol. 37:1999;925-930
50. Klein EA, Thompson IM, Lippman SM, et al. SELECT: the selenium and vitamin E cancer prevention trial. Urol Oncol. 21:2003;59-65
51. McKeown-Eyssen G, Holloway C, Jazmaji V, Bright-See E, Dion P, Bruce WR. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res. 48:1988;4701-4705
52. Roncucci L, Di Donato P, Carati L, et al. Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the health-care district 16. Dis Colon Rectum. 36:1993;227-234
53. Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. New Eng J Med. 331:1994;141-147
54. MacLennan R, Macrae F, Bain C, et al. Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project. J Natl Cancer Inst. 87:1995;1760-1766
55. Ponz de Leon M, Roncucci L. Chemoprevention of colorectal tumors: role of lactulose and of other agents. Scand J Gastroenterol. 222:1997;72-75
56. Hofstad B, Almendingen K, Vatn M, et al. Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion. 59:1998;148-156
57. Malila N, Virtamo J, Virtanen M, Albanes D, Tangrea J, Huttunen J. The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers. Cancer Epidemiol Biomarkers Prev. 8:1999;489-493
58. Janne PA, Mayer RJ. Chemoprevention of colorectal cancer. N Engl J Med. 342:2000;1960-1968
59. Shikany JM, Patterson RE, Agurs-Collins T, Anderson G. Antioxidant supplement use in Women's Health Initiative. Prev Med. 36:2003;379-387
60. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: A review. J Am Dietet Assoc. 96:1996;1027-1039
61. Karakaya S, Kavas A. Antimutagenic activities of some foods. J Agricultur Food Chem. 79:1999;237-242
62. Greenwald P, Clifford CK, Milner JA. Diet and cancer prevention. Eur J Cancer. 37:2001;948-965
63. Kaur C, Kapoor HC. Antioxidants in fruits and vegetables - the millennium's health. Int J Food Science Technol. 36:2001;703-725
64. Camire ME, Kantor MA. Dietary supplements: nutritional and legal considerations. Food Technol. 53:1999;87-95
65. Halliwell B. Antioxidants and human disease: a general introduction. Nutr Rev. 55:1997;S44-S51
66. Michels KB, Edward G, Joshipura KJ, et al. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst. 92:2000;1740-1752
67. Botterweck AA, van den Brandt PA, Goldbohm RA. A prospective cohort study on vegetable and fruit consumption and stomach cancer risk in the Netherlands. Am J Epidemiol. 148:1998;842-853
68. Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med. 342:2000;1149-1455
69. Omenn GS. Chemoprevention of lung cancer: the rise and demise of beta-carotene. Annu Rev Public Health. 19:1998;73-99
70. Ritenbaugh C, Streit K, Helfand M. Routine vitamin supplementation to prevent cancer: Summary of evidence from randomized controlled trials. http://www.ahrq.gov/clinic/3rduspstf/vitamins/vitasum.htm (accessed Aug 20, 2004).
71. Shetty P, Atkins D. Update of the evidence from randomized controlled trials, 1999-2002. Routine vitamin supplementation to prevent cancer. http://www.ahrq.gov/clinic/3rduspstf/vitamins/vitupdate.htm (accessed Aug 20, 2004).